Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia
A prospective multicenter study was performed to investigate the clinical and molecular results of intensified double induction therapy including high-dose cytarabine (ara-C) in combination with ATRA in newly diagnosed acute promyelocytic leukemia (APL), followed by consolidation and 3 years mainten...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
04 August 2000
|
| In: |
Leukemia
Year: 2000, Volume: 14, Issue: 8, Pages: 1362-1370 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/sj.leu.2401843 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.leu.2401843 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/2401843 
|
| Author Notes: | E. Lengfelder, A. Reichert, C. Schoch, D. Haase, T. Haferlach, H. Löffler, P. Staib, A. Heyll, W. Seifarth, S. Saussele, C. Fonatsch, W. Gassmann, W.-D. Ludwig, A. Hochhaus, D. Beelen, C. Aul, M.-C. Sauerland, A. Heinecke, R. Hehlmann, B. Wörmann, W. Hiddemann, T. Büchner |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 179951448X | ||
| 003 | DE-627 | ||
| 005 | 20230427072610.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220413s2000 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.leu.2401843 |2 doi | |
| 035 | |a (DE-627)179951448X | ||
| 035 | |a (DE-599)KXP179951448X | ||
| 035 | |a (OCoLC)1341458970 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Lengfelder, Eva |d 1951- |e VerfasserIn |0 (DE-588)1031229779 |0 (DE-627)736022775 |0 (DE-576)378669230 |4 aut | |
| 245 | 1 | 0 | |a Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid |b effects in patients with newly diagnosed acute promyelocytic leukemia |c E. Lengfelder, A. Reichert, C. Schoch, D. Haase, T. Haferlach, H. Löffler, P. Staib, A. Heyll, W. Seifarth, S. Saussele, C. Fonatsch, W. Gassmann, W.-D. Ludwig, A. Hochhaus, D. Beelen, C. Aul, M.-C. Sauerland, A. Heinecke, R. Hehlmann, B. Wörmann, W. Hiddemann, T. Büchner |
| 264 | 1 | |c 04 August 2000 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.04.2022 | ||
| 520 | |a A prospective multicenter study was performed to investigate the clinical and molecular results of intensified double induction therapy including high-dose cytarabine (ara-C) in combination with ATRA in newly diagnosed acute promyelocytic leukemia (APL), followed by consolidation and 3 years maintenance therapy. Fifty-one patients, diagnosed and monitored from December 1994 to June 1999, were evaluated. The median age was 43 (16-60) years. The morphologic diagnosis was M3 in 40 (78%) and M3v in 11 (22%) patients. In 15 (30%) patients the initial white blood cell counts were ⩾5 × 109/l. The cytogenetic or molecular proof of the translocation t(15;17) was a mandatory prerequisite for eligibility. The diagnosis was confirmed by karyotyping in 46 and by RT-PCR of the PML/RARα transcript in 45 cases. The rate of complete hematological remission was 92% and the early death rate 8%. Monitoring of minimal residual disease by RT-PCR of PML/RARα (sensitivity 10−4) showed negativity in 29 of 32 (91%) evaluable cases after induction, in 23 of 25 (92%) after consolidation, and in 27 of 30 (90%) during maintenance, after a median time of 2, 4 and of 18 months after diagnosis, respectively. After a median follow-up of 27 months, the estimated actuarial 2 years overall and event-free survival were both 88% (79, 97), and the 2 years relapse-free survival 96% (90, 100). The high antileukemic efficacy of this treatment strategy is demonstrated by a rapid and extensive reduction of the malignant clone and by a low relapse rate. The results suggest that the intensity of the induction chemotherapy combined with ATRA is one of the factors which may have a critical influence on the outcome of APL. A randomized trial should assess the value of an induction therapy including ATRA and high-dose ara-C in comparison to standard-dose ara-C. | ||
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a general | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Intensive / Critical Care Medicine | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Medicine/Public Health | |
| 650 | 4 | |a Oncology | |
| 700 | 1 | |a Reichert, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haferlach, Claudia |e VerfasserIn |0 (DE-588)1206213272 |0 (DE-627)1691999199 |4 aut | |
| 700 | 1 | |a Haase, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haferlach, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Löffler, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Staib, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heyll, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Seifarth, Wolfgang |d 1960- |e VerfasserIn |0 (DE-588)1042491887 |0 (DE-627)769066453 |0 (DE-576)393988899 |4 aut | |
| 700 | 1 | |a Saußele, Susanne |d 1968- |e VerfasserIn |0 (DE-588)115839860 |0 (DE-627)69162786X |0 (DE-576)29010694X |4 aut | |
| 700 | 1 | |a Fonatsch, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gassmann, Winfried |e VerfasserIn |0 (DE-588)1206211113 |0 (DE-627)1691991953 |4 aut | |
| 700 | 1 | |a Ludwig, Wolf-Dieter |d 1952- |e VerfasserIn |0 (DE-588)140336788 |0 (DE-627)617705488 |0 (DE-576)316480525 |4 aut | |
| 700 | 1 | |a Hochhaus, Andreas |d 1959- |e VerfasserIn |0 (DE-588)1107039339 |0 (DE-627)863321976 |0 (DE-576)474976130 |4 aut | |
| 700 | 1 | |a Beelen, D. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Aul, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sauerland, M.-C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heinecke, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 700 | 1 | |a Wörmann, B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hiddemann, W. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Büchner, T. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 14(2000), 8, Seite 1362-1370 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid effects in patients with newly diagnosed acute promyelocytic leukemia |
| 773 | 1 | 8 | |g volume:14 |g year:2000 |g number:8 |g pages:1362-1370 |g extent:9 |a Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid effects in patients with newly diagnosed acute promyelocytic leukemia |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.leu.2401843 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/2401843 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220413 | ||
| 994 | |a 2000 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |e 60000PH1037003489 |e 61200PH1037003489 |k 0/60000/ |k 1/60000/61200/ |p 19 | ||
| 998 | |g 1107039339 |a Hochhaus, Andreas |m 1107039339:Hochhaus, Andreas |d 60000 |d 61200 |e 60000PH1107039339 |e 61200PH1107039339 |k 0/60000/ |k 1/60000/61200/ |p 14 | ||
| 998 | |g 115839860 |a Saußele, Susanne |m 115839860:Saußele, Susanne |d 60000 |d 61200 |e 60000PS115839860 |e 61200PS115839860 |k 0/60000/ |k 1/60000/61200/ |p 10 | ||
| 998 | |g 1042491887 |a Seifarth, Wolfgang |m 1042491887:Seifarth, Wolfgang |d 60000 |d 61200 |e 60000PS1042491887 |e 61200PS1042491887 |k 0/60000/ |k 1/60000/61200/ |p 9 | ||
| 998 | |g 1031229779 |a Lengfelder, Eva |m 1031229779:Lengfelder, Eva |d 60000 |d 61200 |e 60000PL1031229779 |e 61200PL1031229779 |k 0/60000/ |k 1/60000/61200/ |p 1 |x j | ||
| 999 | |a KXP-PPN179951448X |e 4117246658 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"role":"aut","given":"Eva","display":"Lengfelder, Eva","family":"Lengfelder"},{"family":"Reichert","display":"Reichert, A.","role":"aut","given":"A."},{"display":"Haferlach, Claudia","family":"Haferlach","role":"aut","given":"Claudia"},{"display":"Haase, D.","family":"Haase","given":"D.","role":"aut"},{"family":"Haferlach","display":"Haferlach, T.","given":"T.","role":"aut"},{"family":"Löffler","display":"Löffler, H.","given":"H.","role":"aut"},{"given":"P.","role":"aut","display":"Staib, P.","family":"Staib"},{"family":"Heyll","display":"Heyll, A.","given":"A.","role":"aut"},{"role":"aut","given":"Wolfgang","family":"Seifarth","display":"Seifarth, Wolfgang"},{"role":"aut","given":"Susanne","display":"Saußele, Susanne","family":"Saußele"},{"family":"Fonatsch","display":"Fonatsch, C.","given":"C.","role":"aut"},{"family":"Gassmann","display":"Gassmann, Winfried","given":"Winfried","role":"aut"},{"family":"Ludwig","display":"Ludwig, Wolf-Dieter","given":"Wolf-Dieter","role":"aut"},{"role":"aut","given":"Andreas","family":"Hochhaus","display":"Hochhaus, Andreas"},{"role":"aut","given":"D.","display":"Beelen, D.","family":"Beelen"},{"given":"C.","role":"aut","family":"Aul","display":"Aul, C."},{"display":"Sauerland, M.-C.","family":"Sauerland","given":"M.-C.","role":"aut"},{"given":"A.","role":"aut","family":"Heinecke","display":"Heinecke, A."},{"family":"Hehlmann","display":"Hehlmann, Rüdiger","role":"aut","given":"Rüdiger"},{"display":"Wörmann, B.","family":"Wörmann","role":"aut","given":"B."},{"display":"Hiddemann, W.","family":"Hiddemann","role":"aut","given":"W."},{"family":"Büchner","display":"Büchner, T.","role":"aut","given":"T."}],"recId":"179951448X","relHost":[{"part":{"year":"2000","pages":"1362-1370","issue":"8","text":"14(2000), 8, Seite 1362-1370","extent":"9","volume":"14"},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid effects in patients with newly diagnosed acute promyelocytic leukemiaLeukemia","pubHistory":["Nachgewiesen 11.1997 -"],"note":["Gesehen am 15.03.04"],"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","dateIssuedDisp":"1997-"}],"title":[{"title":"Leukemia","title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal"}],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"recId":"32046699X","physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"9 S."}],"name":{"displayForm":["E. Lengfelder, A. Reichert, C. Schoch, D. Haase, T. Haferlach, H. Löffler, P. Staib, A. Heyll, W. Seifarth, S. Saussele, C. Fonatsch, W. Gassmann, W.-D. Ludwig, A. Hochhaus, D. Beelen, C. Aul, M.-C. Sauerland, A. Heinecke, R. Hehlmann, B. Wörmann, W. Hiddemann, T. Büchner"]},"id":{"eki":["179951448X"],"doi":["10.1038/sj.leu.2401843"]},"title":[{"title_sort":"Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid","subtitle":"effects in patients with newly diagnosed acute promyelocytic leukemia","title":"Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid"}],"note":["Gesehen am 13.04.2022"],"origin":[{"dateIssuedKey":"2000","dateIssuedDisp":"04 August 2000"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a LENGFELDERDOUBLEINDU0420 | ||